-
Another innovative drug has been returned by Bristol Myers Squibb, with consecutive returns possibly related to strategic adjustments
Recently, at the 2024 Annual Meeting of the European Society of Medical Oncology (ESMO), Immatics announced the latest clinical data of IMA401, a TCR (T-cell binding receptor) bispecific molecular pr ... -
Research firm predicts: Apple may launch smart rings to challenge Samsung in the health field
Research firm predicts that Apple may launch a smart ring to challenge Samsung in the health field. Analysis suggests that Samsung hopes that the Galaxy Ring can help the company lock users into its ... -
The election is approaching! Musk's 2 trillion yuan budget cut plan shakes the market, may these stocks soar?
As the US presidential election approaches, investment experts are closely monitoring the policy positions of the two candidates and their potential market impact. Both Trump and Harris' victories co ...